Frontlight ResearchEarly access
SuspendedNo phase
Upper GI Serial Tumour Biopsies
Key facts
- Who runs it
- The Christie NHS Foundation Trust
- Where
- United Kingdom1 site in 1 countryChoose a country to see its locations
- Trial code
- Status
- Suspended
- People taking part
- 300 people, planned
- Started
- 25 Jan 2022
- Expected to end
- Oct 2028
- Type of study
- Observational
- Treatments tested
- Minor endoscopic biopsy
- Record updated
- 8 February 2024
- Why it stopped
- To explore alternative funding streams
Who can take part
- Age
- 18 years to 100 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (9)Hide the full registry criteria
Who can take part
- Age of 18 years or more
- Patients must have given written informed consent
- Evidence of locally advanced or metastatic oesophageal and gastric carcinoma, i.e. stage III or IV disease
- Accessible tumour that can be safely biopsied using radiological or surgical techniques (if consenting to part A)
- Full blood count and coagulation tests within acceptable parameters (if consenting to part A)
Who cannot take part
- History of significant bleeding disorder (patients on anticoagulation are eligible if the anticoagulation can be safely managed to allow fresh tumour biopsies and blood sampling)
- History of HIV, Hepatitis B/C or other transmissible human disease
- Any conditions where research biopsies or blood sampling may increase risk of complications for the patient and/or investigator, including high risk groups such as intravenous drug users
- Inability to provide informed consent
Where is this trial?
It has locations in one country. Choose a country to see its locations.
What happens in this trial
What the trial wants to find out
This is a prospective translational research study in which tumour samples, blood samples and other biospecimens will be requested from patients with locally advanced or metastatic malignant oesophageal and gastric carcinoma. There are two parts to the study:
Read full original descriptionShow less
* Part A - evaluation of serial tumour biopsies * Part B - evaluation of circulating biomarkers and other biospecimens
The group in the trial
- All participants
All eligible, consented participants, will be asked to give blood, tissue, and other biospecimens for research purposes
Treatment: Minor endoscopic biopsy
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Molecular Characterisation of Serial Tumour Samples and Their Correlation With Circulating Biomarkers and Other Biospecimens Taken During the Clinical Course of Patients Receiving Treatment for Upper Gastrointestinal Carcinomas.
- Record updated
- 8 February 2024